Alloplex Biotherapeutics - Crunchbase Company Profile & Funding

Q: Who invested in Alloplex Biotherapeutics?

Alloplex Biotherapeutics has 2 investors including HanAll Biopharma And Daewoong Pharmaceutical.

Q: How much funding has Alloplex Biotherapeutics raised to date?

Alloplex Biotherapeutics has raised obfuscated.

Overview

Alloplex Biotherapeutics

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Alloplex Biotherapeutics

CB Rank

49931

Alloplex Biotherapeutics develops a cellular therapeutic platform for treating cancer.

Founded

obfuscation

Private

Series A

Boston, Massachusetts, United States

1-10

www.alloplexbio.com/

Biopharma

Biotechnology

Health Care

Therapeutics

Funding Rounds

Series A

OBF

obfuscation

Corporate Round

OBF

obfuscation

Seed

OBF

obfuscation

Key People

Frank Borriello: Founder and CEO

Details

Legal Name

Alloplex Biotherapeutics, LLC

Operating Status

Active

Company Type

For Profit

Founders

Frank Borriello

About the Company

Alloplex Biotherapeutics operates as a privately-owned Boston-based cellular therapeutics company. It has developed a non-engineered, tumor-agnostic cellular therapy platform with broad anti-tumor activity.

Predictions & Insights

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Growth Insight

Products & Services

ENLIST Platform

A patented immune cell training platform that activates multiple immune pathways to generate anti-tumor immune cells from patient blood samples.

SUPLEXA Therapeutic Cells

An autologous, non-engineered cellular therapy derived from patient immune cells, designed to target and kill solid tumor cells while sparing healthy cells.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - Alloplex Biotherapeutics	—	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - Alloplex Biotherapeutics	—	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - Alloplex Biotherapeutics	—	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - Alloplex Biotherapeutics	—	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - Alloplex Biotherapeutics	—	obfuscated obfuscation	—	Series A

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - Alloplex Biotherapeutics	—	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - Alloplex Biotherapeutics	—	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - Alloplex Biotherapeutics	—	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - Alloplex Biotherapeutics	—	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - Alloplex Biotherapeutics	—	obfuscated obfuscation	—	Series A

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
HanAll Biopharma	—	Corporate Round - Alloplex Biotherapeutics	—
HanAll Biopharma	—	Corporate Round - Alloplex Biotherapeutics	—
HanAll Biopharma	—	Corporate Round - Alloplex Biotherapeutics	—
HanAll Biopharma	—	Corporate Round - Alloplex Biotherapeutics	—
HanAll Biopharma	—	Corporate Round - Alloplex Biotherapeutics	—